My Companies
Notification
Account
Log Out
Login
FDC International received UK MHRA marketing authorisation for Atropine 1.0% w/v Eye Drops, Solution. Context: extends the company’s ongoing international approval pipeline; no commercial launch or financial impact was disclosed.
No events have occurred recently